The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.

To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus Medical Countermeasure.

TEL AVIV, Israel and RALEIGH, N.C., Sept. 5, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its first ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Ebola viruses (EBOVs) assemble into ...

Join gambling expert Chris “The Bear” Fallica alongside former NFL Offensive Lineman Geoff Schwartz discuss Ohio State vs. Tennessee, Clemson vs. Texas and more in the CFB Week 17 Super Six. DECEMBER ...

Outbreaks of Ebolaviruses, such as Sudanvirus (SUDV) in Uganda in 2022, demonstrate that species other than the Zaire ebolavirus (EBOV), which is currently the sole virus represented in current ...

Background Heterologous immunity is the induction of an immune response to an unrelated pathogen upon exposure to a different pathogen, involving memory T cells and B cells response. Studies showed ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Article Views are the COUNTER-compliant sum of full text article downloads since ...

Etoricoxib (Ebov (120 mg)) is a non-steroidal anti-inflammatory drug (NSAID), prescribed for osteoarthritis, rheumatoid arthritis and gouty arthritis.It blocks a substance in the body named as ...

The Ebola virus (EBOV) genome encodes for a limited number of proteins and depends on host factors to facilitate viral replication. Identification and characterization of host–viral interactions are ...